Microparticle uptake reduces efferocytic capacity of macrophages

Shivangi Mishra1, Bharti Aggarwal2, Prem Singh Anant1

  • 1Department of Bioengineering, G08 TSH Building, Indian Institute of Science, Bengaluru, India - 560012. siddharth@iisc.ac.in.

Insights

Large microparticles impair macrophage efferocytosis, particularly in naive cells. This effect, absent in activated macrophages, can slow tumor growth by reducing apoptotic cell clearance in the tumor microenvironment (TME).

Area of Science:

  • Immunology
  • Cell Biology
  • Biomaterials

Background:

  • Macrophages are crucial immune cells for clearing pathogens and apoptotic cells.
  • Particle uptake enhances pathogen clearance but its effect on efferocytosis is unknown.
  • Efferocytosis contributes to an immunosuppressive tumor microenvironment (TME).

Purpose of the Study:

  • To investigate how microparticle uptake affects macrophage efferocytic function.
  • To explore the potential of modulating efferocytosis for therapeutic benefit in the TME.

Main Methods:

  • Utilized cargo-free, non-stimulatory polymeric microparticles (∼3 µm and 500 nm) in primary mouse macrophages.
  • Assessed efferocytic capacity in vitro across different macrophage polarization states (M0, M1, M2).
  • Evaluated the therapeutic potential in a 4T1 tumor-bearing BALB/C mouse model.

Main Results:

  • Uptake of large (∼3 µm) microparticles, but not smaller ones, reduced efferocytosis in M0 macrophages.
  • This impairment was polarization-dependent, being absent in activated M1 and M2 macrophages.
  • Direct injection of large microparticles into tumors slowed tumor growth in vivo.

Conclusions:

  • Specific-sized microparticles can modulate macrophage efferocytic function.
  • This modulation, particularly the reduction in efferocytosis by naive macrophages, can be leveraged to alter the TME.
  • Targeting efferocytosis via microparticle administration offers a potential therapeutic strategy for cancer treatment.